SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-014598
Filing Date
2023-05-15
Accepted
2023-05-15 16:25:35
Documents
15
Period of Report
2023-05-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tmbr20230509_8k.htm   iXBRL 8-K 24975
2 EXHIBIT 99.1 ex_517022.htm EX-99.1 86852
7 logo01.jpg GRAPHIC 2924
  Complete submission text file 0001437749-23-014598.txt   257907

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tmbr-20230515.xsd EX-101.SCH 3601
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tmbr-20230515_def.xml EX-101.DEF 11532
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tmbr-20230515_lab.xml EX-101.LAB 15414
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tmbr-20230515_pre.xml EX-101.PRE 11688
9 EXTRACTED XBRL INSTANCE DOCUMENT tmbr20230509_8k_htm.xml XML 2564
Mailing Address 3 MOUNTAINVIEW ROAD, SUITE 100 WARREN NJ 07059
Business Address 3 MOUNTAINVIEW ROAD, SUITE 100 WARREN NJ 07059 (917) 697-3130
Timber Pharmaceuticals, Inc. (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37411 | Film No.: 23922968
SIC: 2834 Pharmaceutical Preparations